Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1

Inhibiting human immunodeficiency virus type 1 (HIV-1) infection by blocking the host cell coreceptors CCR5 and CXCR4 is an emerging strategy for antiretroviral therapy. Currently, several novel coreceptor inhibitors are being developed in the clinic, and early results have proven promising. In this...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Strizki, Julie M., Tremblay, Cecile, Xu, Serena, Wojcik, Lisa, Wagner, Nicole, Gonsiorek, Waldemar, Hipkin, R. William, Chou, Chuan-Chu, Pugliese-Sivo, Catherine, Xiao, Yushi, Tagat, Jayaram R., Cox, Kathleen, Priestley, Tony, Sorota, Steve, Huang, Wei, Hirsch, Martin, Reyes, Gregory R., Baroudy, Bahige M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2005
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1315929/
https://ncbi.nlm.nih.gov/pubmed/16304152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.12.4911-4919.2005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi